Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Martin Felsenthal

OTHER INVESTOR TYPE
Active STATUS
1 PROFESSIONALS
Description

Mr. Martin Felsenthal serves as Partner at Health Velocity Capital. He has worked exclusively with innovative, disruptive, and rapidly growing healthcare software and services companies for more than 20 years. He was previously a partner at two leading venture and growth capital firms focused on this sector -- Salix Ventures and HLM Venture Partners - and also worked with Madison Dearborn Partners earlier in his career. He has led investments in and/or served on the Boards of Directors of companies such as TelaDoc (NYSE: TDOC); Change Healthcare (acquired by Emdeon); Aperio (acquired by Leica Biosystems); Titan Health (acquired by United Surgical Partners); US Renal Care (acquired by Leonard Green); Payerpath (acquired by Misys/Allscripts); Vantage Oncology (acquired by McKesson); NovoLogix (acquired by CVS Health); VeriCare (acquired by MedOptions); OnShift; and ClearData Networks. Marty received his AB from Princeton University and his MBA from the Stanford University Graduate School of Business.

Investor Status
Actively Seeking New Investments
Primary Investor Type
Angel (individual)
Primary Office
  • Cleveland, OH
  • United States
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Martin Felsenthal’s full profile, request a free trial.

Martin Felsenthal Team (1)

Name Title Deals Funds Boards Office Contact
Info
Martin Felsenthal Angel Investor 00 0 0 Cleveland, OH